Table of Contents Global Overactive Bladder Therapeutics Market Professional Survey Report 2017 1 Industry Overview of Overactive Bladder Therapeutics 1.1 Definition and Specifications of Overactive Bladder Therapeutics 1.1.1 Definition of Overactive Bladder Therapeutics 1.1.2 Specifications of Overactive Bladder Therapeutics 1.2 Classification of Overactive Bladder Therapeutics 1.2.1 Global Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023) 1.2.2 Global Overactive Bladder Therapeutics Production Market Share (%) by Types in 2017 1.2.3 Anti-Muscarinic Agent 1.2.4 Beta-3-Adrenergic Receptor Agonist 1.2.5 Others 1.3 Applications of Overactive Bladder Therapeutics 1.3.1 Global Overactive Bladder Therapeutics Consumption (K Units) Comparison by Applications (2012-2023) 1.3.2 Medical Care 1.3.3 Medical Research 1.3.4 Others 1.4 Global Overactive Bladder TherapeuticsMarket by Regions (2012-2023) 1.4.1 Global Overactive Bladder Therapeutics Market Size and Growth Rate (%) Comparison by Regions (2012-2023) 1.4.2 North AmericaOveractive Bladder Therapeutics Status and Prospect (2012-2023) 1.4.3 EuropeOveractive Bladder Therapeutics Status and Prospect (2012-2023) 1.4.4 ChinaOveractive Bladder Therapeutics Status and Prospect (2012-2023) 1.4.5 JapanOveractive Bladder Therapeutics Status and Prospect (2012-2023) 1.4.6 Southeast AsiaOveractive Bladder Therapeutics Status and Prospect (2012-2023) 1.5 Global Overactive Bladder Therapeutics Market Size (2012-2023) 1.5.1 Global Overactive Bladder Therapeutics Revenue (Million USD) Status and Outlook (2012-2023) 1.5.2 Global Overactive Bladder Therapeutics Capacity, Production (K Units) Status and Outlook (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Overactive Bladder Therapeutics 2.2 Raw Material Analysis of Overactive Bladder Therapeutics 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Overactive Bladder Therapeutics 2.4 Other Costs Analysis of Overactive Bladder Therapeutics 2.5 Manufacturing Cost Structure Analysis of Overactive Bladder Therapeutics 2.6 Manufacturing Process Analysis of Overactive Bladder Therapeutics 2.7 Raw Materials Sources of Overactive Bladder Therapeutics Major Manufacturers in 2017 2.8 Downstream Buyers of Overactive Bladder Therapeutics 3 Global Overactive Bladder Therapeutics Manufacturers Profiles/Analysis 3.1 Actavis 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.1.2.1 Anti-Muscarinic Agent 3.1.2.2 Beta-3-Adrenergic Receptor Agonist 3.1.2.3 Others 3.1.3 Actavis 2017 Overactive Bladder Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.1.4 Actavis 2017 Business Region Distribution Analysis 3.1.5 Actavis Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.2 Allergan 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.2.2.1 Anti-Muscarinic Agent 3.2.2.2 Beta-3-Adrenergic Receptor Agonist 3.2.2.3 Others 3.2.3 Allergan 2017 Overactive Bladder Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.2.4 Allergan 2017 Business Region Distribution Analysis 3.2.5 Allergan Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.3 Astellas Pharma 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.3.2.1 Anti-Muscarinic Agent 3.3.2.2 Beta-3-Adrenergic Receptor Agonist 3.3.2.3 Others 3.3.3 Astellas Pharma 2017 Overactive Bladder Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.3.4 Astellas Pharma 2017 Business Region Distribution Analysis 3.3.5 Astellas Pharma Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.4 Pfizer 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.4.2.1 Anti-Muscarinic Agent 3.4.2.2 Beta-3-Adrenergic Receptor Agonist 3.4.2.3 Others 3.4.3 Pfizer 2017 Overactive Bladder Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.4.4 Pfizer 2017 Business Region Distribution Analysis 3.4.5 Pfizer Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.5 Addex Pharmaceuticals Ltd 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.5.2.1 Anti-Muscarinic Agent 3.5.2.2 Beta-3-Adrenergic Receptor Agonist 3.5.2.3 Others 3.5.3 Addex Pharmaceuticals Ltd 2017 Overactive Bladder Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.5.4 Addex Pharmaceuticals Ltd 2017 Business Region Distribution Analysis 3.5.5 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.6 Bayer 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.6.2.1 Anti-Muscarinic Agent 3.6.2.2 Beta-3-Adrenergic Receptor Agonist 3.6.2.3 Others 3.6.3 Bayer Overactive Bladder Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.6.4 Bayer 2017 Business Region Distribution Analysis 3.6.5 Bayer Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.7 Elbion 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.7.2.1 Anti-Muscarinic Agent 3.7.2.2 Beta-3-Adrenergic Receptor Agonist 3.7.2.3 Others 3.7.3 Elbion 2017 Overactive Bladder Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.7.4 Elbion 2017 Business Region Distribution Analysis 3.7.5 Elbion Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.8 Ipsen 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.8.2.1 Anti-Muscarinic Agent 3.8.2.2 Beta-3-Adrenergic Receptor Agonist 3.8.2.3 Others 3.8.3 Ipsen 2017 Overactive Bladder Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.8.4 Ipsen 2017 Business Region Distribution Analysis 3.8.5 Ipsen Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.9 Janssen 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.9.2.1 Anti-Muscarinic Agent 3.9.2.2 Beta-3-Adrenergic Receptor Agonist 3.9.2.3 Others 3.9.3 Janssen 2017 Overactive Bladder Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.9.4 Janssen 2017 Business Region Distribution Analysis 3.9.5 Janssen Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.10 Kissei Pharma 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.10.2.1 Anti-Muscarinic Agent 3.10.2.2 Beta-3-Adrenergic Receptor Agonist 3.10.2.3 Others 3.10.3 Kissei Pharma 2017 Overactive Bladder Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.10.4 Kissei Pharma 2017 Business Region Distribution Analysis 3.10.5 Kissei Pharma Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 4 Technical Data and Manufacturing Plants Analysis of Overactive Bladder Therapeutics 4.1 Capacity and Commercial Production Date of Global Overactive Bladder Therapeutics Major Manufacturers in 2017 4.2 Manufacturing Plants Distribution of Global Overactive Bladder Therapeutics Major Manufacturers in 2017 4.4 R&D Status and Technology Source of Global Overactive Bladder Therapeutics Major Manufacturers in 2017 4.4 Raw Materials Sources Analysis of Global Overactive Bladder Therapeutics Major Manufacturers in 2017 5 Global Overactive Bladder Therapeutics Overall Market Overview 5.1 2012-2017 Overall Market Analysis 5.2 Capacity Analysis 5.2.1 2012-2017 Global Overactive Bladder Therapeutics Capacity and Growth Rate Analysis 5.2.2 2017 Overactive Bladder Therapeutics Capacity Analysis (Company Segment) 5.3 Sales Analysis 5.3.1 2012-2017 Global Overactive Bladder Therapeutics Sales and Growth Rate Analysis 5.3.2 2017 Overactive Bladder Therapeutics Sales Analysis (Company Segment) 5.4 Sales Price Analysis 5.4.1 2012-2017 Global Overactive Bladder Therapeutics Sales Price 5.4.2 2017 Overactive Bladder Therapeutics Sales Price Analysis (Company Segment) 6 Overactive Bladder Therapeutics Regional Market Analysis 6.1 North America Overactive Bladder Therapeutics Market Analysis 6.1.1 North America Overactive Bladder Therapeutics Market Overview 6.1.2 North America 2012-2017 Overactive Bladder Therapeutics Local Supply, Import, Export, Local Consumption Analysis 6.1.3 North America 2012-2017 Overactive Bladder Therapeutics Sales Price Analysis 6.1.4 North America 2017 Overactive Bladder Therapeutics Market Share Analysis 6.2 Europe Overactive Bladder Therapeutics Market Analysis 6.2.1 Europe Overactive Bladder Therapeutics Market Overview 6.2.2 Europe 2012-2017 Overactive Bladder Therapeutics Local Supply, Import, Export, Local Consumption Analysis 6.2.3 Europe 2012-2017 Overactive Bladder Therapeutics Sales Price Analysis 6.2.4 Europe 2017 Overactive Bladder Therapeutics Market Share Analysis 6.3 China Overactive Bladder Therapeutics Market Analysis 6.3.1 China Overactive Bladder Therapeutics Market Overview 6.3.2 China 2012-2017 Overactive Bladder Therapeutics Local Supply, Import, Export, Local Consumption Analysis 6.3.3 China 2012-2017 Overactive Bladder Therapeutics Sales Price Analysis 6.3.4 China 2017 Overactive Bladder Therapeutics Market Share Analysis 6.4 Japan Overactive Bladder Therapeutics Market Analysis 6.4.1 Japan Overactive Bladder Therapeutics Market Overview 6.4.2 Japan 2012-2017 Overactive Bladder Therapeutics Local Supply, Import, Export, Local Consumption Analysis 6.4.3 Japan 2012-2017 Overactive Bladder Therapeutics Sales Price Analysis 6.4.4 Japan 2017 Overactive Bladder Therapeutics Market Share Analysis 6.5 Southeast Asia Overactive Bladder Therapeutics Market Analysis 6.5.1 Southeast Asia Overactive Bladder Therapeutics Market Overview 6.5.2 Southeast Asia 2012-2017 Overactive Bladder Therapeutics Local Supply, Import, Export, Local Consumption Analysis 6.5.3 Southeast Asia 2012-2017 Overactive Bladder Therapeutics Sales Price Analysis 6.5.4 Southeast Asia 2017 Overactive Bladder Therapeutics Market Share Analysis 6.6 India Overactive Bladder Therapeutics Market Analysis 6.6.1 India Overactive Bladder Therapeutics Market Overview 6.6.2 India 2012-2017 Overactive Bladder Therapeutics Local Supply, Import, Export, Local Consumption Analysis 6.6.3 India 2012-2017 Overactive Bladder Therapeutics Sales Price Analysis 6.6.4 India 2017 Overactive Bladder Therapeutics Market Share Analysis 7 Global 2012-2017 Overactive Bladder Therapeutics Segment Market Analysis (by Type) 7.1 Global 2012-2017 Overactive Bladder Therapeutics Sales by Type 7.2 Different Types of Overactive Bladder Therapeutics Product Interview Price Analysis 7.3 Different Types of Overactive Bladder Therapeutics Product Driving Factors Analysis 7.3.1 Anti-Muscarinic Agent of Overactive Bladder Therapeutics Growth Driving Factor Analysis 7.3.2 Beta-3-Adrenergic Receptor Agonist of Overactive Bladder Therapeutics Growth Driving Factor Analysis 7.3.3 Others of Overactive Bladder Therapeutics Growth Driving Factor Analysis 8 Global 2012-2017 Overactive Bladder Therapeutics Segment Market Analysis (by Application) 8.1 Global 2012-2017 Overactive Bladder Therapeutics Consumption by Application 8.2 Different Application of Overactive Bladder Therapeutics Product Interview Price Analysis 8.3 Different Application of Overactive Bladder Therapeutics Product Driving Factors Analysis 8.3.1 Medical Care of Overactive Bladder Therapeutics Growth Driving Factor Analysis 8.3.2 Medical Research of Overactive Bladder Therapeutics Growth Driving Factor Analysis 8.3.3 Others of Overactive Bladder Therapeutics Growth Driving Factor Analysis 9 Development Trend of Analysis of Overactive Bladder Therapeutics Market 9.1 Global Overactive Bladder Therapeutics Market Trend Analysis 9.1.1 Global 2018-2023 Overactive Bladder Therapeutics Market Size (Volume and Value) Forecast 9.1.2 Global 2018-2023 Overactive Bladder Therapeutics Sales Price Forecast 9.2 Overactive Bladder Therapeutics Regional Market Trend 9.2.1 North America 2018-2023 Overactive Bladder Therapeutics Consumption Forecast 9.2.2 Europe 2018-2023 Overactive Bladder Therapeutics Consumption Forecast 9.2.3 China 2018-2023 Overactive Bladder Therapeutics Consumption Forecast 9.2.4 Japan 2018-2023 Overactive Bladder Therapeutics Consumption Forecast 9.2.5 Southeast Asia 2018-2023 Overactive Bladder Therapeutics Consumption Forecast 9.2.6 India 2018-2023 Overactive Bladder Therapeutics Consumption Forecast 9.3 Overactive Bladder Therapeutics Market Trend (Product Type) 9.4 Overactive Bladder Therapeutics Market Trend (Application) 10 Marketing Strategy Analysis, Distributors/Traders 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List 11 Overactive Bladder Therapeutics Marketing Type Analysis 11.1 Overactive Bladder Therapeutics Regional Marketing Type Analysis 11.2 Overactive Bladder Therapeutics International Trade Type Analysis 11.3 Traders or Distributors with Contact Information of Overactive Bladder Therapeutics by Region 11.4 Overactive Bladder Therapeutics Supply Chain Analysis 12 Consumers Analysis of Overactive Bladder Therapeutics 12.1 Consumer 1 Analysis 12.2 Consumer 2 Analysis 12.3 Consumer 3 Analysis 12.4 Consumer 4 Analysis 13 Conclusion of the Global Overactive Bladder Therapeutics Market Professional Survey Report 2018 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables and Figures Figure Global Market Size (Million USD) Status and Outlook 2012-2023 Table Global Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions (2012-2023) Table Global Overactive Bladder Therapeutics Production (K Units) and Revenue (Million USD) Market Split by Product Type Table Global Overactive Bladder Therapeutics Consumption (K Units) by Application (2016-2023) Figure Picture of Overactive Bladder Therapeutics Table Product Specifications of Overactive Bladder Therapeutics Table Global Overactive Bladder Therapeutics Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Global Overactive Bladder Therapeutics Production Market Share (%) by Types in 2017 Figure Anti-Muscarinic Agent Picture Table Major Manufacturers of Anti-Muscarinic Agent Figure Beta-3-Adrenergic Receptor Agonist Picture Table Major Manufacturers of Beta-3-Adrenergic Receptor Agonist Figure Others Picture Table Major Manufacturers of Others Table Global Overactive Bladder Therapeutics Consumption (K Units) Comparison by Applications (2012-2023) Figure Global Overactive Bladder Therapeutics Consumption (K Units) Market Share (%) by Applications in 2017 Figure Medical Care Picture Figure Medical Research Picture Figure Others Picture Table Global Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions (2012-2023) Figure North America Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure India Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Global Overactive Bladder Therapeutics Revenue (Million USD) Status and Outlook (2012-2023) Figure Global Overactive Bladder Therapeutics Capacity, Production (K Units) Status and Outlook (2012-2023) Figure Industry Chain Structure of Overactive Bladder Therapeutics Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Overactive Bladder Therapeutics in 2017 Figure Manufacturing Process Analysis of Overactive Bladder Therapeutics Table Raw Materials Sources of Overactive Bladder Therapeutics Major Manufacturers in 2017 Table Major Buyers of Overactive Bladder Therapeutics Table Actavis Information List Table Anti-Muscarinic Agent Overactive Bladder Therapeutics Overview Table Beta-3-Adrenergic Receptor Agonist Overactive Bladder Therapeutics Overview Table Others Overactive Bladder Therapeutics Overview Table 2017 Actavis Overactive Bladder Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Actavis Overactive Bladder Therapeutics Business Region Distribution Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Actavis Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Actavis Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Actavis Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Allergan Information List Table Anti-Muscarinic Agent Overactive Bladder Therapeutics Overview Table Beta-3-Adrenergic Receptor Agonist Overactive Bladder Therapeutics Overview Table Others Overactive Bladder Therapeutics Overview Table 2017 Allergan Overactive Bladder Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Allergan Overactive Bladder Therapeutics Business Region Distribution Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Allergan Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Allergan Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Allergan Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Astellas Pharma Information List Table Anti-Muscarinic Agent Overactive Bladder Therapeutics Overview Table Beta-3-Adrenergic Receptor Agonist Overactive Bladder Therapeutics Overview Table 2017 Astellas Pharma Overactive Bladder Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Astellas Pharma Overactive Bladder Therapeutics Business Region Distribution Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Astellas Pharma Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Astellas Pharma Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Astellas Pharma Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Pfizer Information List Table Anti-Muscarinic Agent Overactive Bladder Therapeutics Overview Table Beta-3-Adrenergic Receptor Agonist Overactive Bladder Therapeutics Overview Table Others Overactive Bladder Therapeutics Overview Table 2017 Pfizer Overactive Bladder Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Pfizer Overactive Bladder Therapeutics Business Region Distribution Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Pfizer Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Pfizer Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Addex Pharmaceuticals Ltd Information List Table Anti-Muscarinic Agent Overactive Bladder Therapeutics Overview Table Beta-3-Adrenergic Receptor Agonist Overactive Bladder Therapeutics Overview Table 2017 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Business Region Distribution Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Bayer Information List Table Anti-Muscarinic Agent Overactive Bladder Therapeutics Overview Table Beta-3-Adrenergic Receptor Agonist Overactive Bladder Therapeutics Overview Table 2017 Bayer Overactive Bladder Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Bayer Overactive Bladder Therapeutics Business Region Distribution Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bayer Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Bayer Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Bayer Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Elbion Information List Table Anti-Muscarinic Agent Overactive Bladder Therapeutics Overview Table Beta-3-Adrenergic Receptor Agonist Overactive Bladder Therapeutics Overview Table 2017 Elbion Overactive Bladder Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Elbion Overactive Bladder Therapeutics Business Region Distribution Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Elbion Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Elbion Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Ipsen Information List Table Anti-Muscarinic Agent Overactive Bladder Therapeutics Overview Table Beta-3-Adrenergic Receptor Agonist Overactive Bladder Therapeutics Overview Table 2017 Ipsen Overactive Bladder Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Ipsen Overactive Bladder Therapeutics Business Region Distribution Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Ipsen Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Ipsen Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Ipsen Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Janssen Information List Table Anti-Muscarinic Agent Overactive Bladder Therapeutics Overview Table Beta-3-Adrenergic Receptor Agonist Overactive Bladder Therapeutics Overview Table 2017 Janssen Overactive Bladder Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Janssen Overactive Bladder Therapeutics Business Region Distribution Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Janssen Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Janssen Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Kissei Pharma Information List Table Anti-Muscarinic Agent Overactive Bladder Therapeutics Overview Table Beta-3-Adrenergic Receptor Agonist Overactive Bladder Therapeutics Overview Table 2017 Kissei Pharma Overactive Bladder Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Kissei Pharma Overactive Bladder Therapeutics Business Region Distribution Table Anti-Muscarinic Agent Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Kissei Pharma Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Kissei Pharma Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Kissei Pharma Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Capacity (K Units) and Commercial Production Date of Global Overactive Bladder Therapeutics Major Manufacturers in 2017 Table Manufacturing Plants Distribution of Global Overactive Bladder Therapeutics Major Manufacturers in 2017 Table R&D Status and Technology Source of Global Overactive Bladder Therapeutics Major Manufacturers in 2017 Table Raw Materials Sources Analysis of Global Overactive Bladder Therapeutics Major Manufacturers in 2017 Table Global Capacity (K Units), Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of Overactive Bladder Therapeutics 2012-2017 Figure Global 2012-2017 Overactive Bladder Therapeutics Sales (K Units) and Growth Rate Figure Global 2012-2017 Overactive Bladder Therapeutics Market Size (Million USD) and Growth Rate Figure 2012-2017 Global Overactive Bladder Therapeutics Capacity and Growth Rate Table 2017 Global Overactive Bladder Therapeutics Capacity List (Company Segment) Figure 2012-2017 Global Overactive Bladder Therapeutics Sales and Growth Rate Table 2017 Global Overactive Bladder Therapeutics Sales List (Company Segment) Figure 2012-2017 Global Overactive Bladder Therapeutics Sales Price Table 2017 Global Overactive Bladder Therapeutics Sales Price List (Company Segment) Figure North America Capacity Overview Figure North America 2017 Overactive Bladder Therapeutics Capacity Market Share Table North America Supply, Import, Export and Consumption of Overactive Bladder Therapeutics 2012-2017 (K Units) Figure North America 2012-2017 Overactive Bladder Therapeutics Sales Price (USD/Unit) Figure North America 2017 Overactive Bladder Therapeutics Sales Market Share Figure Europe Capacity Overview Figure Europe 2017 Overactive Bladder Therapeutics Capacity Market Share Table Europe Supply, Import, Export and Consumption of Overactive Bladder Therapeutics 2012-2017 (K Units) Figure Europe 2012-2017 Overactive Bladder Therapeutics Sales Price (USD/Unit) Figure North America 2017 Overactive Bladder Therapeutics Sales Market Share Figure China Capacity Overview Figure China 2017 Overactive Bladder Therapeutics Capacity Market Share Table China Supply, Import, Export and Consumption of Overactive Bladder Therapeutics 2012-2017 (K Units) Figure China 2012-2017 Overactive Bladder Therapeutics Sales Price (USD/Unit) Figure China 2017 Overactive Bladder Therapeutics Sales Market Share Figure Japan Capacity Overview Figure Japan 2017 Overactive Bladder Therapeutics Capacity Market Share Table Japan Supply, Import, Export and Consumption of Overactive Bladder Therapeutics 2012-2017 (K Units) Figure Japan 2012-2017 Overactive Bladder Therapeutics Sales Price (USD/Unit) Figure Japan 2017 Overactive Bladder Therapeutics Sales Market Share Figure Southeast Asia Capacity Overview Figure Southeast Asia 2017 Overactive Bladder Therapeutics Capacity Market Share Table Southeast Asia Supply, Import, Export and Consumption of Overactive Bladder Therapeutics 2012-2017 (K Units) Figure Southeast Asia 2012-2017 Overactive Bladder Therapeutics Sales Price (USD/Unit) Figure Southeast Asia 2017 Overactive Bladder Therapeutics Sales Market Share Figure India Capacity Overview Figure India 2017 Overactive Bladder Therapeutics Capacity Market Share Table India Supply, Import, Export and Consumption of Overactive Bladder Therapeutics 2012-2017 (K Units) Figure India 2012-2017 Overactive Bladder Therapeutics Sales Price (USD/Unit) Figure India 2017 Overactive Bladder Therapeutics Sales Market Share Table Global 2012-2017 Overactive Bladder Therapeutics Sales by Type Table Different Types Overactive Bladder Therapeutics Product Interview Price Table Global 2012-2017 Overactive Bladder Therapeutics Sales by Application Table Different Application Overactive Bladder Therapeutics Product Interview Price Figure Global 2018-2023 Overactive Bladder Therapeutics Sales (K Units) and Growth Rate Forecast Figure Global 2018-2023 Overactive Bladder Therapeutics Market Size (Million USD) and Growth Rate Forecast Figure Global 2018-2023 Overactive Bladder Therapeutics Sales Price (USD/Unit) Forecast Figure North America 2018-2023 Overactive Bladder Therapeutics Consumption Volume and Growth Rate Forecast Figure Europe 2018-2023 Overactive Bladder Therapeutics Consumption Volume and Growth Rate Forecast Figure China 2018-2023 Overactive Bladder Therapeutics Consumption Volume and Growth Rate Forecast Figure Japan 2018-2023 Overactive Bladder Therapeutics Consumption Volume and Growth Rate Forecast Figure Southeast Asia 2018-2023 Overactive Bladder Therapeutics Consumption Volume and Growth Rate Forecast Figure India 2018-2023 Overactive Bladder Therapeutics Consumption Volume and Growth Rate Forecast Table Global Sales Volume (K Units) of Overactive Bladder Therapeutics by Beta-3-Adrenergic Receptor Agonist2018-2023 Table Global Consumption Volume (K Units) of Overactive Bladder Therapeutics by Medical Research2018-2023 Table Distributors/Traders List Table Traders or Distributors with Contact Information of Overactive Bladder Therapeutics by Regions Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Actavis Allergan Astellas Pharma Pfizer Addex Pharmaceuticals Ltd Bayer Elbion Ipsen Janssen Kissei Pharma